Merck and Intercell terminate Phase II/III clinical trial of V710
8 June 2011 | By Merck
DMC recommends termination of the evaluation of investigational Staphylococcus aureus vaccine, V710...
List view / Grid view
News
Thermo Fisher Scientific launches new GC-MS/MS instrument for superior selectivity and sensitivity at ASMS 2011
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new triple quadrupole gas chromatography-mass spectrometry (GC-MS/MS) system designed to offer best-in-class selectivity, analytical performance and productivity.
New research into the production of proteins with extended circulatory half-life
7 June 2011 | By The Scott Partnership
The latest research into the development of proteins...
In shifting regulatory climate Greenphire unveils latest clinical payment solutions at DIA 2011
7 June 2011 | By The Scott Partnership
Greenphire, showcase its ground breaking clinical payment solutions including ClinCard...
Biogen Idec receives approval in the European Union for AVONEX(R) PEN(TM)
7 June 2011 | By Biogen Idec
Biogen Idec announced that the European Commission has granted approval to AVONEX PEN...
New data in breast and ovarian cancer presented at ASCO support continued development of Iniparib
6 June 2011 | By Sanofi
Sanofi announced new data for iniparib (BSI-201)...
Children in the world’s poorest countries could receive vaccination against rotavirus diarrhoeal disease
6 June 2011 | By GlaxoSmithKline
GSK has made a new offer to supply its rotavirus vaccine, to the GAVI Alliance...
Merck and ARIAD announce presentation of results of Phase III SUCCEED trial
6 June 2011 | By Merck
Merck and ARIAD Pharmaceuticals, Inc., announced the presentation of detailed results from the Phase III SUCCEED clinical trial...
ALMSCO International highlights its BenchTOF-dx for improved sensitivity
6 June 2011 | By The Scott Partnership
ALMSCO International, showcasing its state-of-the-art bench-top TOF mass spectrometer, BenchTOF-dx at ASMS 2011...
Thermo Fisher Scientific introduces new capabilities for comprehensive qualitative and quantitative proteomics
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new capabilities for laboratories performing a wide range of qualitative and quantitative proteomics workflows.
Novartis gains European Commission approval for Lucentis®
6 June 2011 | By Novartis
The European Commission has granted Novartis a new indication for Lucentis® (ranibizumab)...
ZALTRAP™ (aflibercept) significantly improved survival in previously treated metastatic colorectal cancer patients
6 June 2011 | By Sanofi
Data will be presented at the ESMO World Congress on Gastrointestinal Cancer...
Merck commends GAVI Alliance on continued efforts to improve access
5 June 2011 | By Merck
Merck commends the GAVI Alliance for their commitment to protecting the lives of children...
Patients with deadly form of lung cancer lived longer without disease worsening
5 June 2011 | By Eli Lilly and Company
Eli Lilly and Company announced that PARAMOUNT, met its primary endpoint of progression-free survival...
Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
5 June 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (NYSE: BMY) today announced results from a second Phase 3 randomized, double blind study...
